Biotech News
Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results
Reports third quarter 2026 total revenue of $9.5 million, representing 22% growth compared to the third quarter of 2025 Placed 7 Growth Direct systems and completed 12 validations in the third quarter of 2026 Reports record third quarter 2026 total gross margin of 25%, an increase of 16 percentage
